piracetam has been researched along with Aphasia in 15 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a prospective, double-blind, placebo-controlled study, it was investigated whether piracetam improves language recovery in poststroke aphasia assessed by neuropsychological tests and activation PET measurement of cerebral blood flow." | 9.09 | Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. ( Heiss, WD; Karbe, H; Kessler, J; Thiel, A, 2000) |
| "Electroencephalographic and clinical effects of piracetam in post-stroke aphasia were evaluated in a prospective, randomized, double-blind, placebo-controlled trial." | 9.09 | Restitution of alpha-topography by piracetam in post-stroke aphasia. ( Heiss, WD; Kessler, J; Mielke, R; Szelies, B, 2001) |
| "Piracetam appears to have a positive adjuvant effect on the recovery of aphasia in patients receiving intensive language therapy." | 9.08 | Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study. ( Deberdt, W; Huber, W; Poeck, K; Van Vleymen, B; Willmes, K, 1997) |
| "We performed a systematic review and meta-analysis to assess whether piracetam facilitates the rehabilitation of language performance in post-stroke patients." | 8.93 | Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Chen, Z; Luo, B; Wei, R; Zhang, J, 2016) |
| "Piracetam has been shown to improve speech in aphasic patients." | 6.40 | The role of piracetam in the treatment of acute and chronic aphasia. ( Huber, W, 1999) |
| "In a prospective, double-blind, placebo-controlled study, it was investigated whether piracetam improves language recovery in poststroke aphasia assessed by neuropsychological tests and activation PET measurement of cerebral blood flow." | 5.09 | Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. ( Heiss, WD; Karbe, H; Kessler, J; Thiel, A, 2000) |
| "Electroencephalographic and clinical effects of piracetam in post-stroke aphasia were evaluated in a prospective, randomized, double-blind, placebo-controlled trial." | 5.09 | Restitution of alpha-topography by piracetam in post-stroke aphasia. ( Heiss, WD; Kessler, J; Mielke, R; Szelies, B, 2001) |
| "Piracetam appears to have a positive adjuvant effect on the recovery of aphasia in patients receiving intensive language therapy." | 5.08 | Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study. ( Deberdt, W; Huber, W; Poeck, K; Van Vleymen, B; Willmes, K, 1997) |
| "We performed a systematic review and meta-analysis to assess whether piracetam facilitates the rehabilitation of language performance in post-stroke patients." | 4.93 | Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. ( Chen, Z; Luo, B; Wei, R; Zhang, J, 2016) |
| "Pharmacotherapy of aphasia had been discussed for the last twenty years with first bromocriptine and amphetamine and then serotoninergic, GABAergic and cholinergic agents." | 4.84 | Pharmacotherapy of aphasia: myth or reality? ( de Boissezon, X; de Boysson, C; Démonet, JF; Peran, P, 2007) |
| "The main conclusion of this review is that drug treatment with piracetam may be effective in the treatment of aphasia after stroke." | 4.81 | Pharmacological treatment for aphasia following stroke. ( Enderby, P; Greener, J; Whurr, R, 2001) |
| "We report the case of an aborted awake craniotomy for a left frontotemporoinsular glioma due to ammonia encephalopathy on a patient taking Levetiracetam, valproic acid and clobazam." | 3.81 | Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy. ( Arroyo Pérez, R; Fernández-Candil, JL; León Jorba, A; Pacreu Terradas, S; Villalba Martínez, G; Vivanco-Hidalgo, RM, 2015) |
| " However, EEG was abnormal and the boy was diagnosed as a case of Landau-Kleffner syndrome (LKS) and treated with sodium valproate, levetiracetam and steroids." | 3.81 | Landau-Kleffner syndrome: an uncommon dealt with case in Southeast Asia. ( Afsar, S; Dixit, NS; Motwani, N; Sharma, N, 2015) |
| "Piracetam has been shown to improve speech in aphasic patients." | 2.40 | The role of piracetam in the treatment of acute and chronic aphasia. ( Huber, W, 1999) |
| "Aphasia is a language disorder characterised by loss of ability to produce or comprehend written or spoken language." | 1.48 | Adult-onset epileptic aphasia. ( Guerra, D; Marques Mendes, E; Mendes, A; Ribeiro, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marques Mendes, E | 1 |
| Mendes, A | 1 |
| Ribeiro, C | 1 |
| Guerra, D | 1 |
| Villalba Martínez, G | 1 |
| Fernández-Candil, JL | 1 |
| Vivanco-Hidalgo, RM | 1 |
| Pacreu Terradas, S | 1 |
| León Jorba, A | 1 |
| Arroyo Pérez, R | 1 |
| Motwani, N | 1 |
| Afsar, S | 1 |
| Dixit, NS | 1 |
| Sharma, N | 1 |
| Zhang, J | 1 |
| Wei, R | 1 |
| Chen, Z | 1 |
| Luo, B | 1 |
| Güngör, L | 1 |
| Terzi, M | 1 |
| Onar, MK | 1 |
| Schmidtke, K | 1 |
| de Boissezon, X | 1 |
| Peran, P | 1 |
| de Boysson, C | 1 |
| Démonet, JF | 1 |
| Deberdt, W | 3 |
| Huber, W | 2 |
| Willmes, K | 1 |
| Poeck, K | 1 |
| Van Vleymen, B | 1 |
| Enderby, P | 2 |
| Broeckx, J | 1 |
| Hospers, W | 1 |
| Schildermans, F | 1 |
| Orgogozo, JM | 1 |
| Kessler, J | 2 |
| Thiel, A | 1 |
| Karbe, H | 1 |
| Heiss, WD | 2 |
| Szelies, B | 1 |
| Mielke, R | 1 |
| Greener, J | 1 |
| Whurr, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Escitalopram and Language Intervention for Subacute Aphasia (ELISA)[NCT03843463] | Phase 2 | 88 participants (Anticipated) | Interventional | 2021-07-18 | Recruiting | ||
| A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia[NCT06010030] | 200 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | |||
| Effects of tDCS in Language Recovery and Reorganization in Chronic Aphasia[NCT04166513] | 4 participants (Anticipated) | Interventional | 2019-12-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for piracetam and Aphasia
| Article | Year |
|---|---|
Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Topics: Aphasia; Humans; Language Disorders; Piracetam; Randomized Controlled Trials as Topic; Stroke; Treat | 2016 |
Pharmacotherapy of aphasia: myth or reality?
Topics: Amphetamine; Aphasia; Bromocriptine; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; | 2007 |
The role of piracetam in the treatment of acute and chronic aphasia.
Topics: Acute Disease; Aphasia; Cerebrovascular Disorders; Chronic Disease; Humans; Nootropic Agents; Pirace | 1999 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
Pharmacological treatment for aphasia following stroke.
Topics: Aphasia; Humans; Neuroprotective Agents; Piracetam; Randomized Controlled Trials as Topic; Stroke | 2001 |
6 trials available for piracetam and Aphasia
| Article | Year |
|---|---|
Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?
Topics: Aphasia; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Piracetam; Single-Blind Method; | 2011 |
Interaction between psychological and pharmacological treatment in cognitive impairment.
Topics: Adolescent; Aged; Aged, 80 and over; Analysis of Variance; Aphasia; Child; Cognition Disorders; Doub | 1994 |
Piracetam as an adjuvant to language therapy for aphasia: a randomized double-blind placebo-controlled pilot study.
Topics: Adult; Aged; Aphasia; Combined Modality Therapy; Data Interpretation, Statistical; Double-Blind Meth | 1997 |
Effect of piracetam on recovery and rehabilitation after stroke: a double-blind, placebo-controlled study.
Topics: Aged; Aphasia; Cerebral Infarction; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropro | 1994 |
Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
Topics: Adolescent; Adult; Aged; Aphasia; Brain; Cerebrovascular Circulation; Combined Modality Therapy; Dou | 2000 |
Restitution of alpha-topography by piracetam in post-stroke aphasia.
Topics: Adult; Aged; Analysis of Variance; Aphasia; Brain Mapping; Double-Blind Method; Electroencephalograp | 2001 |
5 other studies available for piracetam and Aphasia
| Article | Year |
|---|---|
Adult-onset epileptic aphasia.
Topics: Aged; Anticonvulsants; Aphasia; Cerebral Cortex; Electroencephalography; Epilepsy; Female; Humans; L | 2018 |
Ammonia encephalopathy and awake craniotomy for brain language mapping: cause of failed awake craniotomy.
Topics: Anesthesia, General; Anesthesia, Local; Anticonvulsants; Aphasia; Benzodiazepines; Brain Diseases; B | 2015 |
Landau-Kleffner syndrome: an uncommon dealt with case in Southeast Asia.
Topics: Anticonvulsants; Aphasia; Asia, Southeastern; Child; Electroencephalography; Humans; Landau-Kleffner | 2015 |
[Does treatment with piracetam in stroke patients with aphasia make sense?].
Topics: Aphasia; Humans; Neuroprotective Agents; Nootropic Agents; Piracetam; Stroke | 2002 |
Piracetam in the treatment of acute stroke.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aphasia; Cerebrovascular Disorders; Female; Humans; M | 1999 |